These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 23473612)

  • 1. The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011.
    Lièvre A; Artru P; Guiu M; Laurent-Puig P; Merlin JL; Sabourin JC; Viguier J; Bastie A; Seronde A; Ducreux M
    Eur J Cancer; 2013 Jun; 49(9):2126-33. PubMed ID: 23473612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014.
    Lièvre A; Merlin JL; Sabourin JC; Artru P; Tong S; Libert L; Audhuy F; Gicquel C; Moureau-Zabotto L; Ossendza RA; Laurent-Puig P; Ducreux M
    Dig Liver Dis; 2018 May; 50(5):507-512. PubMed ID: 29396127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observational study on conditions for access to the analysis of KRAS mutation in patients with metastatic colorectal cancer receiving panitumumab treatment].
    Bibeau F; Louvet C; Afchain P; Mitry E; Artru P; André T
    Bull Cancer; 2012; 99(7-8):743-51. PubMed ID: 22735045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.
    Mariani P; Lae M; Degeorges A; Cacheux W; Lappartient E; Margogne A; Pierga JY; Girre V; Mignot L; Falcou MC; Salmon RJ; Delattre O; De Cremoux P
    Anticancer Res; 2010 Oct; 30(10):4229-35. PubMed ID: 21036746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
    Sebio A; Paré L; Páez D; Salazar J; González A; Sala N; del Río E; Martín-Richard M; Tobeña M; Barnadas A; Baiget M
    Pharmacogenet Genomics; 2013 Mar; 23(3):142-7. PubMed ID: 23324806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
    Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
    Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized cancer treatment and the myth of KRAS wild-type colon tumors.
    Parsons BL; Myers MB
    Discov Med; 2013 Apr; 15(83):259-67. PubMed ID: 23636143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.
    Normanno N; Pinto C; Castiglione F; Bardelli A; Gambacorta M; Botti G; Nappi O; Siena S; Ciardiello F; Taddei G; Marchetti A
    PLoS One; 2011; 6(12):e29146. PubMed ID: 22216189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumorous heterogeneity for RAS mutations in a treatment-naïve colorectal tumour.
    Lunke S; Lee B; Kranz S; Gibbs P; Waring P; Christie M
    J Clin Pathol; 2017 Aug; 70(8):720-723. PubMed ID: 28314739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of RAS genes mutation using the Cobas
    Albertini AF; Raoux D; Neumann F; Rossat S; Tabet F; Pedeutour F; Duranton-Tanneur V; Kubiniek V; Vire O; Weinbreck N
    Bull Cancer; 2017; 104(7-8):662-674. PubMed ID: 28688743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
    Chong CY; Jalali A; Wong HL; Loft M; Wong R; Lee M; Gately L; Hong W; Shapiro J; Kosmider S; Tie J; Ananda S; Yeung JM; Ma B; Burge M; Jennens R; Tran B; Lee B; Lim L; Dean A; Nott L; Gibbs P
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e363-e368. PubMed ID: 35073441
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Greenbaum A; Wiggins C; Meisner AL; Rojo M; Kinney AY; Rajput A
    Heliyon; 2017 Nov; 3(11):e00448. PubMed ID: 29202108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Epidermal Growth Factor Receptor Maintenance Therapy in Metastatic Colorectal Cancer-Another Piece to the Puzzle.
    Morano F; Pietrantonio F
    JAMA Netw Open; 2023 Sep; 6(9):e2333488. PubMed ID: 37721757
    [No Abstract]   [Full Text] [Related]  

  • 14. Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
    Palmieri LJ; Mineur L; Tougeron D; Rousseau B; Granger V; Gornet JM; Smith D; Lievre A; Galais MP; Doat S; Pernot S; Bignon-Bretagne AL; Metges JP; Baba-Hamed N; Michel P; Obled S; Vitellius C; Bouche O; Saban-Roche L; Buecher B; des Guetz G; Locher C; Trouilloud I; Goujon G; Dior M; Manfredi S; Soularue E; Phelip JM; Henriques J; Vernery D; Coriat R
    Oncologist; 2020 Feb; 25(2):e266-e275. PubMed ID: 32043796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor mutational burden in non-small cell lung cancer-the pathologist's point of view.
    Penault-Llorca F; Radosevic-Robin N
    Transl Lung Cancer Res; 2018 Dec; 7(6):716-721. PubMed ID: 30505716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant
    Ng AWR; Tan PJ; Hoo WPY; Liew DS; Teo MYM; Siak PY; Ng SM; Tan EW; Abdul Rahim R; Lim RLH; Song AAL; In LLA
    PeerJ; 2018; 6():e5056. PubMed ID: 30042874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors influencing molecular testing at diagnostic of colorectal cancer.
    Thiebault Q; Defossez G; Karayan-Tapon L; Ingrand P; Silvain C; Tougeron D
    BMC Cancer; 2017 Nov; 17(1):765. PubMed ID: 29137623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS testing in metastatic colorectal cancer: advances in Europe.
    Van Krieken JH; Rouleau E; Ligtenberg MJ; Normanno N; Patterson SD; Jung A
    Virchows Arch; 2016 Apr; 468(4):383-96. PubMed ID: 26573425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis.
    Carter GC; Landsman-Blumberg PB; Johnson BH; Juneau P; Nicol SJ; Li L; Shankaran V
    J Exp Clin Cancer Res; 2015 Mar; 34(1):29. PubMed ID: 25888436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.